Legal & General Group
OBIO icon

Legal & General Group’s Orchestra BioMed OBIO Stock Holding History

Legal & General Group’s Portfolio OBIO Stock Details OBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.9K Buy
+3,924
New +$16K ﹤0.01% 3191
2025
Q2 		– Sell
-2,225
Closed -$9.52K – 3499
2025
Q1 		$9.52K Hold
2,225
– – ﹤0.01% 3181
2024
Q4 		$8.89K Hold
2,225
– – ﹤0.01% 3273
2024
Q3 		$11.4K Hold
2,225
– – ﹤0.01% 3246
2024
Q2 		$18.1K Buy
2,225
+717
+48% +$4.15K ﹤0.01% 3061
2024
Q1 		$7.95K Hold
1,508
– – ﹤0.01% 3250
2023
Q4 		$13.8K Hold
1,508
– – ﹤0.01% 3168
2023
Q3 		$13.2K Sell
1,508
-7,630
-83% -$51.3K ﹤0.01% 3202
2023
Q2 		$63.9K Buy
+9,138
New +$139K ﹤0.01% 2854

Other funds holding OBIO

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Legal & General Group's OBIO Position: Q2 2026 in Review

Legal & General Group opened a new position in Orchestra BioMed (OBIO) in Q2 2026: 3,924 shares worth $16.9K. The stake represents ﹤0.01% of the portfolio and ranks #3191 among its holdings. This is a return to the name: Legal & General Group previously reported a position in OBIO as recently as Q1 2025.

Legal & General Group first reported a position in OBIO in Q2 2023 and has held it in 9 quarters since. The position peaked at $63.9K in Q2 2023. 77 funds tracked by Wall St. Rank hold OBIO as of Q2 2026.

  • Legal & General Group held 3,924 shares of Orchestra BioMed worth $16.9K as of Q2 2026.
  • Orchestra BioMed was a new Legal & General Group position in Q2 2026.
  • Orchestra BioMed made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #3191 holding.
  • Legal & General Group first reported a position in Orchestra BioMed in Q2 2023 and has held it in 9 quarters since.
  • Legal & General Group's Orchestra BioMed position peaked at $63.9K in Q2 2023.
  • 77 funds tracked by Wall St. Rank held Orchestra BioMed as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.